24_10_STREAM_SiteHeader_BO

REGULATORY

7:41 483595200-data-transformation
An Efficient And Reliable Way To Digitalize Your Sterility And QC Testing Data

Watch to learn about the M-Trace™ Electronic Test Record Software, your digital QC companion for trusted and efficient data recording that automizes and digitalizes your sterility and QC testing data.

1:52 Feature
Simplifying Bioprocess Data Collection

Centralized bioprocess data collection and aggregation lowers the risk of data loss during any manual retrieval process. Discover a solution that helps you meet data storage and reporting requirements.

2:59 aes-faciliflex
Faciliflex Cleanroom Module For Therapeutic Drug Manufacturing

The Faciliflex Module is a transformational new concept in designing cleanrooms for the production of lifesaving therapeutics.

0:59 GettyImages-1226044009-lab-virus-dna-research-cleanroom
The ICH Q5A Revision, Its New Scope And Guidance

Learn about the ICH Q5A revision addressing viral safety of biotechnology products derived from cell lines of human or animal origin that was recently published for public comment.

52:39 24_01_BoB_1280x720_Ep162
Facing NASH Therapeutic Skepticism With 89bio's Rohan Palekar

The non-alcoholic steatohepatitis (NASH) therapeutics market has proven to be an 11/10 on the difficulty scale. Despite billions of big biopharma dollars invested in therapeutic development, and a few close calls, no therapeutics has yet reached the finish line.

1:19 Millipore video
Strategies To Reduce Regulatory Risks In Gene Therapy

Learn how to mitigate regulatory risk for your gene therapy process.

46:11 24_12_LSC_ExecutiveRoundtable_Splash_1280x720
Executive Roundtable: Cell Therapy Predictions For 2025 And Beyond

In this executive roundtable discussion, Bioprocess Online editor Tyler Menichiello is joined by CEO, co-founder, and president of Ossium Health, Kevin Caldwell, CSO of FibroBiologics, Hamid Khoja, Ph.D., and president and acting CEO of Triumvira Immunologics, Ro...

1:48 Millipore
Level Up With Product Characterization

In the race to bring a new biotherapeutic to market, unexpected obstacles can slow you down or even knock you back a few steps. But with the right information at the right time, and an experienced partner to provide scientific, regulatory, and bioprocessing guidance and s...